Hubert Beaumont

Valbonne, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Dual-modality CAD for breast cancer screening: dealing with discordant diagnosis between mammography and tomography.

Dual-modality CAD for breast cancer screening: dealing with discordant diagnosis between mammography and tomography.

Journal: Frontiers in oncology
Published: November 02, 2025

Technical performance of L3 skeletal muscle area (SMA) measurement on CT for L3 skeletal muscle index (L3SMI) assessment.

Technical performance of L3 skeletal muscle area (SMA) measurement on CT for L3 skeletal muscle index (L3SMI) assessment.

Journal: Scientific reports
Published: October 16, 2025

What are RECIST 1.1 progressions made of? Variability in double-read oncology trials.

What are RECIST 1.1 progressions made of? Variability in double-read oncology trials.

Journal: European radiology
Published: February 12, 2025

Radiomics-Based Prediction of Treatment Response to TRuC-T Cell Therapy in Patients with Mesothelioma: A Pilot Study.

Radiomics-Based Prediction of Treatment Response to TRuC-T Cell Therapy in Patients with Mesothelioma: A Pilot Study.

Journal: Cancers
Published: December 16, 2024

RECIST 1.1 assessments variability: a systematic pictorial review of blinded double reads.

RECIST 1.1 assessments variability: a systematic pictorial review of blinded double reads.

Journal: Insights into imaging
Published: March 28, 2024

The ins and outs of errors in oncology imaging: the DAC framework for radiologists.

The ins and outs of errors in oncology imaging: the DAC framework for radiologists.

Journal: Frontiers in oncology
Published: March 18, 2024

Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?

Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?

Journal: Frontiers in oncology
Published: June 13, 2023

Breaking down the RECIST 1.1 double read variability in lung trials: What do baseline assessments tell us?

Breaking down the RECIST 1.1 double read variability in lung trials: What do baseline assessments tell us?

Journal: Frontiers in oncology
Published: July 07, 2022

Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?

Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?

Journal: Cancer medicine
Published: November 24, 2021

Correction to: Intra-scan inter-tissue variability can help harmonize radiomics features in CT.

Correction to: Intra-scan inter-tissue variability can help harmonize radiomics features in CT.

Journal: European radiology
Published: September 24, 2021

Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials.

Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials.

Journal: Cancers
Published: May 21, 2021

Letter to the editor: "Not all biases are bad: equitable and inequitable biases in machine learning and radiology".

Letter to the editor: "Not all biases are bad: equitable and inequitable biases in machine learning and radiology".

Journal: Insights into imaging
Published: March 21, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026